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1. INTRODUCTION {#mbo3873-sec-0001}
===============

The liver has numerous functions, including metabolism, bile secretion, glycogen storage, hematopoiesis, and immunity (Knell, [1980](#mbo3873-bib-0039){ref-type="ref"}). The liver also detoxifies endogenous and exogenous substances, including medicines (Brockmoller & Roots, [1994](#mbo3873-bib-0006){ref-type="ref"}), which may be harmful. However, liver pathology rarely results in clinical signs until the extent of the injury is severe; therefore, this organ should be carefully protected. The liver receives 70% of its blood supply from the gut *via* the portal vein (Krarup, Larsen, & Madsen, [1975](#mbo3873-bib-0041){ref-type="ref"}), suggesting that this organ is the first to encounter absorbed nutrients, antigens, toxins, and microorganisms. The direct connection between the gut and the liver implies that the intestinal microbiome or its products will affect the liver.

The gut microbiome consists of more than 10^4^ species and \~10^14^ individual cells. The species and the number of cells of each species vary substantially in the intestine and according to host factors, including age, diet, and sex (Orrhage & Nord, [2000](#mbo3873-bib-0065){ref-type="ref"}). The homeostasis of the gut microbiome plays an important role in physical health by affecting the functions of various visceral organs and may also affect mental health (Ivanov & Honda, [2012](#mbo3873-bib-0032){ref-type="ref"}). Previous studies have revealed that a wide variety of hepatic diseases are associated with disturbances in the gut microbiome, such as nonalcoholic steatohepatitis, cirrhosis, alcoholic liver cirrhosis, and hepatic carcinoma (Bajaj et al., [2012](#mbo3873-bib-0003){ref-type="ref"}; Chen et al., [2011](#mbo3873-bib-0009){ref-type="ref"}; Fukui, Brauner, Bode, & Bode, [1991](#mbo3873-bib-0015){ref-type="ref"}; Imajo et al., [2012](#mbo3873-bib-0030){ref-type="ref"}; Lu et al., [2011](#mbo3873-bib-0049){ref-type="ref"}; Qin et al., [2014](#mbo3873-bib-0069){ref-type="ref"}; Rivera, Bradford, Seabra, & Thurman, [1998](#mbo3873-bib-0072){ref-type="ref"}; Tuomisto et al., [2014](#mbo3873-bib-0089){ref-type="ref"}). For instance, alcoholic liver disease is associated with the perturbation of the gut‐liver axis because of large quantities of lipopolysaccharide (LPS), peptidoglycan, bacterial 16S DNA, and other deleterious bacterially derived molecules entering the liver. This perturbation results in macrophage (Kupffer cell) activation and the secretion of inflammatory cytokines, including interleukin (IL)‐6 and IL‐1β, and reactive oxygen species; this, in turn, increases the permeability and inflammation of the gut, creating a vicious circle. In addition, the activation of stellate cells results in the increased expression of α‐smooth muscle actin and collagen, which contribute to liver fibrosis and cirrhosis (Szabo, [2015](#mbo3873-bib-0081){ref-type="ref"}).

Studies of hepatic progenitor cells (HPCs) have significantly progressed in recent years. As early as 1958, Wilson and Leduc identified bipotential liver progenitor cells that could differentiate into hepatic parenchymal cells or into biliary epithelial cells (Wilson & Leduc, [1958](#mbo3873-bib-0092){ref-type="ref"}). By altering the culture conditions of these cells, several laboratories have been able to replicate this bidirectional differentiation in vitro (Furuyama et al., [2011](#mbo3873-bib-0016){ref-type="ref"}; Hao et al., [2013](#mbo3873-bib-0025){ref-type="ref"}; Huch et al., [2013](#mbo3873-bib-0029){ref-type="ref"}; Li et al., [2006](#mbo3873-bib-0045){ref-type="ref"}; Suzuki et al., [2008](#mbo3873-bib-0080){ref-type="ref"}). HPCs account for \<1% of the total number of liver cells, with almost all of these cells being dormant and located around the Hering ducts. However, when the liver is subjected to sustained damage, such as that resulting from the intraperitoneal injection of carbon tetrachloride (Petersen, Zajac, & Michalopoulos, [1998](#mbo3873-bib-0067){ref-type="ref"}), bile duct ligation (Irie et al., [2007](#mbo3873-bib-0031){ref-type="ref"}; Mu et al., [2017](#mbo3873-bib-0062){ref-type="ref"}; Wu, Ma, Gibson, Hirai, & Tsukada, [1981](#mbo3873-bib-0095){ref-type="ref"}), choline‐deficient and ethionine‐supplemented diet (Akhurst et al., [2001](#mbo3873-bib-0002){ref-type="ref"}; Passman et al., [2015](#mbo3873-bib-0066){ref-type="ref"}), methionine‐choline‐deficient diet (Morell et al., [2017](#mbo3873-bib-0060){ref-type="ref"}), thioacetamide diet or partial hepatectomy (Chien et al., [2018](#mbo3873-bib-0010){ref-type="ref"}; Grzelak et al., [2014](#mbo3873-bib-0021){ref-type="ref"}; Kohn‐Gaone et al., [2016](#mbo3873-bib-0040){ref-type="ref"}; Lu et al., [2016](#mbo3873-bib-0050){ref-type="ref"}), HPCs are stimulated to proliferate and to protect and regenerate the injured liver. The source of HPCs remains controversial. Some researchers contend that these cells exist in a quiescent state around bile ducts until activated (Tee, Kirilak, Huang, Morgan, & Yeoh, [1994](#mbo3873-bib-0086){ref-type="ref"}; Tee, Smith, & Yeoh, [1992](#mbo3873-bib-0087){ref-type="ref"}), while other researchers contend that some HPCs originate from hepatocytes (Wu & Lee, [2017](#mbo3873-bib-0093){ref-type="ref"}) or from an extrahepatic source, especially bone marrow (Li et al., [2011](#mbo3873-bib-0044){ref-type="ref"}; Zhai et al., [2018](#mbo3873-bib-0100){ref-type="ref"}). In addition, recent studies have indicated that HPCs originate from the transdifferentiation of biliary epithelial cells (Raven et al., [2018](#mbo3873-bib-0070){ref-type="ref"}). However, it has not been established whether the disturbance of the gut microbiome influences HPC activation.

In this study, we treated C57BL/6 mice with five broad‐spectrum antibiotics for 14 days at the maximum dose to eliminate their gut microbes. Subsequently, we assessed the serum biochemical indices and quantified the expression of the progenitor cell marker SRY‐related high mobility group‐box gene 9 (SOX9) (Lo, Chan, Leung, & Ng, [2018](#mbo3873-bib-0048){ref-type="ref"}; Pozniak et al., [2017](#mbo3873-bib-0068){ref-type="ref"}; Tarlow, Finegold, & Grompe, [2014](#mbo3873-bib-0085){ref-type="ref"}). The plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities were not significantly higher in the treated mice than they were in the control mice, but the triglyceride (TG), lactate dehydrogenase (LDH), low‐density lipoprotein (LDL), and high‐density lipoprotein (HDL) concentrations were all affected. In addition, the expression levels of SOX9 (*p* \< 0.0001) and the progenitor cell marker cytokeratin (CK) (Russell et al., [2019](#mbo3873-bib-0073){ref-type="ref"}) were significantly higher in the livers of the antibiotic‐treated mice than their expression levels in the control mice. The mechanism of these effects may involve the induction of inflammation because the expression levels of proinflammatory factors (IL‐1β, IL‐6, tumor necrosis factor (TNF)‐α, and TWEAK) were also higher. These results indicate that the elimination of the intestinal flora impairs liver function and activates HPCs. These findings add to our understanding of gut‐liver and microbiome‐liver interactions and of the regulation of HPC activation.

2. RESULTS {#mbo3873-sec-0002}
==========

2.1. Depletion of the gut microbiome results in cecal enlargement and increased colonic permeability {#mbo3873-sec-0003}
----------------------------------------------------------------------------------------------------

To deplete the intestinal microbiome, male C57BL/6 mice were treated with an antibiotic cocktail containing meropenem, neomycin sulfate, natamycin, bacitracin, and vancomycin in their drinking water for 14 days (Abx mice). The selected antibiotics do not reach the liver *via* enterohepatic circulation, which excludes the possibility of direct effects on the liver (Frohlich et al., [2016](#mbo3873-bib-0014){ref-type="ref"}; Guida et al., [2018](#mbo3873-bib-0023){ref-type="ref"}; Heimesaat et al., [2006](#mbo3873-bib-0026){ref-type="ref"}; Mohle et al., [2016](#mbo3873-bib-0058){ref-type="ref"}). The ceca of the Abx mice were obviously larger than those of the control mice (Figure [1](#mbo3873-fig-0001){ref-type="fig"}a), such that the ratio of cecal mass to body mass of the Abx mice was substantially higher than that of the control mice (Figure [1](#mbo3873-fig-0001){ref-type="fig"}b). This cecal enlargement suggests that the gut microbiome plays an important role in the maintenance of intestinal morphology and health. Next, 16S rDNA quantitative polymerase chain reaction (qPCR) was also performed (Figure [1](#mbo3873-fig-0001){ref-type="fig"}c), which demonstrated that the vast majority of gut microbes had been eliminated. Colonic hematoxylin and eosin (H&E) staining showed that the crypt length was obviously decreased and that the number of goblet cells was largely reduced (Figure [1](#mbo3873-fig-0001){ref-type="fig"}d,e). Goblet cells secrete the mucus layer, which protects the colonic epithelium from the contents of the lumen. The poor changes in crypt length and goblet cell number indicated that the colonic epithelium was damaged. To further confirm this finding, the tight junction protein ZO‐1 was analyzed by real‐time PCR and immunochemistry (Figure [1](#mbo3873-fig-0001){ref-type="fig"}f,g). Both the mRNA and protein levels were significantly reduced in the Abx mice compared to those in the control mice.

![Cecal enlargement is induced by the maximum depletion of the gut microbiome. (a) Representative images of the cecum in control and Abx mice. (b) Cecal mass/body mass in control and Abx mice. (c) 16S rRNA analysis of Abx and control mice. (d) Representative colonic H&E‐stained images. (e) Colonic crypt length comparison. (f) Tight junction protein ZO‐1 relative mRNA level. (g) Representative immunochemistry images of ZO‐1 expression. In all panels, the data are expressed as the mean ± SEM; control (*n* = 8), Abx (*n* = 8); \*\**p* \< 0.01 versus control, \*\*\**p* \< 0.0001 versus control. H&E, hematoxylin and eosin](MBO3-8-e873-g001){#mbo3873-fig-0001}

2.2. Depletion of the gut microbiome causes liver dysfunction {#mbo3873-sec-0004}
-------------------------------------------------------------

The maximum depletion of the gut microbiome caused a significant reduction in the ratio of liver mass to body mass (Figure [2](#mbo3873-fig-0002){ref-type="fig"}a). Serum AST and ALT did not differ between the Abx and control mice (Figure [2](#mbo3873-fig-0002){ref-type="fig"}b,c), implying that hepatic parenchymal cells were not lysed as a result of antibiotic treatment. Plasma albumin (ALB) was also unaffected (Figure [2](#mbo3873-fig-0002){ref-type="fig"}d). However, H&E staining of liver sections showed hepatocytomegaly, cytoplasmic rarefaction, and a loss of visible hepatic cord structure (Figure [2](#mbo3873-fig-0002){ref-type="fig"}e,f). In addition, serum LDH, globulin (GLB), TG, HDL‐C, and LDL‐C were all significantly affected by antibiotic treatment (Figure [2](#mbo3873-fig-0002){ref-type="fig"}g--k), implying the presence of hepatic pathology, inflammation, and disordered lipid and cholesterol metabolism.

![Serum biochemical indices and hematoxylin‐eosin (H&E) staining in control and Abx mice. (a) Liver mass/body mass in control and Abx mice. Serum AST (b), ALT (c), and ALB (d) in control and Abx mice. (e) Representative images of H&E staining in control and Abx mice. (f) The lesion area was estimated using PFV analysis of the H&E‐stained images. Serum LDH (g), GLB (h), TG (i), HDL‐C (j), and LDL‐C (k) concentrations in control and Abx mice. (l) Tgfb1 mRNA expression in control and Abx mice. (m) ALR mRNA expression in control and Abx mice. In all panels, the data are expressed as the mean ± SEM; control (*n* = 8), Abx (*n* = 8); \**p* \< 0.05 versus control, \*\**p* \< 0.01 versus control, \*\*\**p* \< 0.0001 versus control. ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GLB, globulin; HDL, high‐density lipoprotein; LDH, low‐density lipoprotein; LDL, low‐density lipoprotein; TG, triglyceride](MBO3-8-e873-g002){#mbo3873-fig-0002}

Transforming growth factor‐beta 1 (TGFB1) is one of the three subtypes of TGF‐β, a multifunctional protein that regulates cell growth, differentiation, apoptosis, the immune response and cellular homeostasis (Heldin, Miyazono, & Ten, [1997](#mbo3873-bib-0027){ref-type="ref"}; Seoane & Gomis, [2017](#mbo3873-bib-0076){ref-type="ref"}; Shi & Massague, [2003](#mbo3873-bib-0078){ref-type="ref"}; Wu & Hill, [2009](#mbo3873-bib-0094){ref-type="ref"}), and hence, can be regarded as a marker of hepatocyte dysfunction (Raven et al., [2018](#mbo3873-bib-0070){ref-type="ref"}). Higher *Tgfb1* expression was found in the livers of Abx mice (Figure [2](#mbo3873-fig-0002){ref-type="fig"}l). Augmenter of liver regeneration (ALR) stimulates hepatocyte proliferation, protects the liver from injury, and participates in organ formation and development (Gandhi, [2012](#mbo3873-bib-0017){ref-type="ref"}; Hongbo et al., [2012](#mbo3873-bib-0028){ref-type="ref"}; Mu et al., [2016](#mbo3873-bib-0061){ref-type="ref"}; Vodovotz et al., [2013](#mbo3873-bib-0090){ref-type="ref"}), and the ALR mRNA expression level was lower in the Abx mice than its expression in the control mice (Figure [2](#mbo3873-fig-0002){ref-type="fig"}m). These results imply that liver dysfunction and morphological changes result from gut microbial ablation.

2.3. Depletion of the gut microbiome in adult mice activates HPCs {#mbo3873-sec-0005}
-----------------------------------------------------------------

SOX9 is important in early embryonic development and is a member of a family of genes homologous to the sex‐determining region of the Y chromosome (*Sry*). The *Sry* gene induces the development of mammalian testes and participates in gender determination. In previous studies, SOX9 has been used as a progenitor or stem cell marker (Hongbo et al., [2012](#mbo3873-bib-0028){ref-type="ref"}; Tanimizu, Nishikawa, Ichinohe, Akiyama, & Mitaka, [2014](#mbo3873-bib-0084){ref-type="ref"}). The mRNA expression of *Sox9* was significantly higher in the livers of Abx mice (Figure [3](#mbo3873-fig-0003){ref-type="fig"}a) than it was in the livers of the control mice, suggesting that HPCs were activated. SOX9 immunohistochemistry (Figure [3](#mbo3873-fig-0003){ref-type="fig"}b) showed that this protein was expressed around the bile ducts in the Abx mice, whereas in the control mice, there were very few SOX9‐expressing cells. The quantification of the SOX9‐positive area per field of view (PFV) is shown in Figure [3](#mbo3873-fig-0003){ref-type="fig"}c.

![The expression levels of the hepatic progenitor cell markers SOX9 and CK were significantly increased by microbiome ablation. (a) *Sox9* mRNA expression was determined by qPCR to be significantly higher in Abx mice than in control mice. (b) Representative immunohistochemical staining for SOX9 in control and Abx mice. (c) The SOX9‐positive area in the control and Abx mice was estimated using PFV analysis. (d) Representative immunohistochemical staining for pan‐CK in control and Abx mice. (e) The pan‐CK‐positive cell number in the control and Abx mice was estimated using PFV analysis. Control (*n* = 8), Abx (*n* = 8); \*\**p* \< 0.01 versus control, \*\*\**p* \< 0.0001 versus control. CK, Cytokeratin; PFV, per field of view; qPCR, quantitative polymerase chain reaction](MBO3-8-e873-g003){#mbo3873-fig-0003}

Cytokeratins are a group of intermediate filament proteins that are expressed in both keratinized and nonkeratinized epithelial tissues. These proteins maintain the overall structural integrity of epithelial cells and play a crucial role in tissue differentiation and specialization. CK expression has therefore been used as a marker of tissue differentiation, for example, to assess tumor malignancy (Barak, Goike, Panaretakis, & Einarsson, [2004](#mbo3873-bib-0004){ref-type="ref"}; Moll, [1998](#mbo3873-bib-0059){ref-type="ref"}; Nicolini, Ferrari, & Rossi, [2015](#mbo3873-bib-0064){ref-type="ref"}) and progenitor cell activation. Immunostaining using a pan‐CK antibody showed that CKs were prominently expressed in the Abx mouse liver but were not expressed in the control mouse liver (Figure [3](#mbo3873-fig-0003){ref-type="fig"}d). The estimated number of pan‐CK‐positive cells PFV is shown in Figure [3](#mbo3873-fig-0003){ref-type="fig"}e. In contrast to the situation of SOX9, a percentage of the stained area was not used to quantify CK expression because in the pan‐CK‐stained sections, positive cells were present in well‐defined borders. These data demonstrate that HPCs are activated following gut microbial depletion.

2.4. Depletion of the gut microbiome is associated with macrophage activation and the higher expression of genes encoding proinflammatory cytokines in the liver {#mbo3873-sec-0006}
----------------------------------------------------------------------------------------------------------------------------------------------------------------

We next explored the mechanism underlying HPC activation following antibiotic treatment. Following antibiotic treatment, the serum LPS level was significantly increased in the Abx mice compared to that in the control mice (Figure [4](#mbo3873-fig-0004){ref-type="fig"}a). According to the literature (Bawa & Saraswat, [2013](#mbo3873-bib-0005){ref-type="ref"}; Malaguarnera, Giordano, Nunnari, Bertino, & Malaguarnera, [2014](#mbo3873-bib-0053){ref-type="ref"}; Szabo, [2015](#mbo3873-bib-0081){ref-type="ref"}; Yang et al., [2019](#mbo3873-bib-0098){ref-type="ref"}), in the gut‐liver axis, LPS is a key component that binds to the toll‐like receptor (TLR) family members to activate macrophages, which are associated with several liver diseases. Because CD68 is a marker of macrophages, we analyzed CD68 protein expression by immunochemistry (Figure [4](#mbo3873-fig-0004){ref-type="fig"}c) and counted the number of marked macrophages (Figure [4](#mbo3873-fig-0004){ref-type="fig"}b). The number of macrophages in the Abx mice was obviously increased compared with that of the control mice. We hypothesized that proinflammatory cytokines might contribute to HPC activation. IL‐6 is a pluripotent cytokine that is principally secreted by macrophages during the acute phase response, inflammation, bone catabolism, hematopoiesis, and cancer progression. IL‐6 could therefore represent a biomarker of disease severity and a prognostic indicator (Ji et al., [2016](#mbo3873-bib-0035){ref-type="ref"}; Rincon, [2012](#mbo3873-bib-0071){ref-type="ref"}). The expression of *IL‐6* was higher than that of *TNF‐α* and *IL‐1β* in the mice and was significantly higher in the Abx mice than it was in the control mice (Figure [4](#mbo3873-fig-0004){ref-type="fig"}d, *p* \< 0.01). IL‐1β, which is secreted by macrophages, is an important mediator of inflammation and has other functions, including cell proliferation, differentiation, and apoptosis (Chung et al., [2015](#mbo3873-bib-0011){ref-type="ref"}; Sato et al., [2014](#mbo3873-bib-0074){ref-type="ref"}; Shrivastava, Mukherjee, Ray, & Ray, [2013](#mbo3873-bib-0079){ref-type="ref"}). IL‐1β expression was also higher in the Abx mice than it was in the control mice (Figure [4](#mbo3873-fig-0004){ref-type="fig"}b). TNF‐α, a cytokine that is produced mainly by activated macrophages, is involved in the systemic inflammatory response and contributes to the acute phase response (Ji et al., [2016](#mbo3873-bib-0035){ref-type="ref"}; Sato et al., [2014](#mbo3873-bib-0074){ref-type="ref"}). The mRNA expression of *TNF‐α* in the Abx mice was higher than that in the control mice (Figure [4](#mbo3873-fig-0004){ref-type="fig"}c). TWEAK is a cytokine produced by macrophages, belongs to the TNF superfamily and may regulate inflammation, cell apoptosis, and proliferation. TWEAK has been shown to be associated with HPC activation in previous studies (Akahori et al., [2015](#mbo3873-bib-0001){ref-type="ref"}; Hamill, Michaelson, Hahm, Burkly, & Kessler, [2007](#mbo3873-bib-0024){ref-type="ref"}; Sheng et al., [2018](#mbo3873-bib-0077){ref-type="ref"}). The mRNA expression of *Tweak* was significantly higher in the Abx mice than it was in the control mice (Figure [4](#mbo3873-fig-0004){ref-type="fig"}d, *p* \< 0.0001). These data may imply that macrophages play a critical role in HPC activation by releasing inflammatory cytokines, especially IL‐6 and TWEAK. Thus, these inflammatory cytokines may be regarded as key targets for more extensive research.

![Inflammatory cytokine expression is much higher in the Abx mice than it is in the control mice. (a) Serum LPS ELISA absorbance value comparison. (b) Representative images of CD68 immunochemistry. Each red arrow indicates a CD68‐positive macrophage. The bottom left corner is the enlarged image, and the brown corners are macrophages. (c) CD68‐positive cell number PFV in control and Abx mice. (d) *IL‐6* mRNA expression was determined by real‐time PCR to be significantly higher in the Abx mice than it was in the control mice. (e) *IL‐1β* mRNA expression was much higher in the Abx mice than that in the control mice. (f) *TNF‐α* mRNA expression was much higher in the Abx mice than that in the control mice. (g) *Tweak* mRNA expression was determined using qPCR to be significantly higher in the Abx mice than that in the control mice. Control (*n* = 8), Abx (*n* = 8); \**p* \< 0.05 versus control, \*\**p* \< 0.01 versus control, \*\*\**p* \< 0.0001 versus control. PFV, per field of view; qPCR, quantitative polymerase chain reaction; LPS, lipopolysaccharide](MBO3-8-e873-g004){#mbo3873-fig-0004}

3. DISCUSSION {#mbo3873-sec-0007}
=============

The depletion of the gut microbiome led to a reduction in liver mass, suggesting that liver function might be impaired. Although the serum ALT and AST activities and the ALB concentration were not affected, H&E staining demonstrated that hepatocytomegaly, cytoplasmic rarefaction, and a loss of hepatic cord structure had occurred, implying liver cell damage. Lipid metabolism (as shown by TG), cholesterol metabolism (as shown by LDL and HDL), glycolysis (as shown by LDH), and inflammatory status (as shown by GLB), were all substantially affected by the depletion of the gut microbiome, confirming hepatocyte dysfunction. Most importantly, we found evidence that HPCs were activated because the progenitor cell markers SOX9 and CK were both expressed at higher levels. Inflammatory cytokines, especially IL‐6 and TWEAK, may mediate this effect.

The gut microbiota and its human host have a symbiotic relationship once the microbiome has been gradually generated and stabilized during the first 1--3 years of life (Milani et al., [2017](#mbo3873-bib-0055){ref-type="ref"}; Tanaka & Nakayama, [2017](#mbo3873-bib-0082){ref-type="ref"}). Various hepatic diseases have been shown to be linked to gut microbial dysbiosis, including nonalcoholic fatty liver disease, alcoholic liver disease, hepatic fibrosis, sclerosis, and hepatic carcinoma. The liver receives two blood supplies: one‐quarter comes from the systemic circulation *via* the hepatic artery, and the other three‐quarters arrive *via* the portal vein from the gut. These two blood supplies suggest that the liver is the first organ to encounter nutrients, antigens, toxins, and other substances absorbed from the gut. This connection has been termed the "gut‐liver axis," and its importance in the pathogenesis of liver diseases has been repeatedly shown since it was first described in 1998 (Seabra, Stachlewitz, & Thurman, [1998](#mbo3873-bib-0075){ref-type="ref"}).

Most of the deleterious effects of gut microbes on the liver are mediated through inflammation (Bawa & Saraswat, [2013](#mbo3873-bib-0005){ref-type="ref"}; Yamada et al., [2017](#mbo3873-bib-0097){ref-type="ref"}), which is triggered by interactions between the microbes, the liver, and the immune system. Key to this process is the interaction of hepatic macrophages (Kupffer cells) with pathogen‐associated molecular patterns (PAMPs). PAMPs, especially endotoxin or LPS, bind to TLRs (Miura & Ohnishi, [2014](#mbo3873-bib-0056){ref-type="ref"}; Miyake & Yamamoto, [2013](#mbo3873-bib-0057){ref-type="ref"}), particularly to TLR4 (Carotti, Guarino, Vespasiani‐Gentilucci, & Morini, [2015](#mbo3873-bib-0007){ref-type="ref"}), and activate Kupffer cells, which attempt to remove pathogens from the liver. As our results show, the depletion of the gut microbiota resulted in massive reductions in goblet cells and significantly shortened the crypt lengths. The expression of the tight junction protein ZO‐1 was decreased in the Abx mice compared to that in the control mice. These results indicate that gut permeability was increased, allowing LPS to penetrate the gut wall and be absorbed into the bloodstream. In line with the above results, the concentration of LPS in the serum was significantly higher in the Abx mice compared to that in the control mice. Moreover, macrophages in the livers of Abx mice were substantially activated. These observations were consistent with previous literature reports that have indicated that LPS activates macrophages (Ghosh, Bie, Wang, & Ghosh, [2014](#mbo3873-bib-0018){ref-type="ref"}). To achieve the removal of pathogens, a series of inflammatory pathways are activated, and a number of cytokines are released. In addition, hepatic stellate cells express TLR4 and are therefore sensitive to LPS. Once these cells are activated by LPS, they produce larger amounts of collagen, which promotes fibrosis.

The greatest current challenge in research on the gut microbiome is to determine whether it plays a causative role in physiological and pathological processes. The current experimental strategies make use of pathogen‐free rodents, antibiotic‐induced microbial modifications, infection with enteric pathogenic bacteria, and transplantation with probiotics or fecal flora. In pathogen‐free mice, fecal bacterial transplantation can be used to study the role of the microbiome in a disease process or to assess the effects of the gut microbial composition during development (Lundberg, Toft, August, Hansen, & Hansen, [2016](#mbo3873-bib-0052){ref-type="ref"}). Given that it is impossible to use this approach in humans, the standard approach remains a combination treatment with multiple antibiotics to ablate the gut microbiome. Antibiotic treatment can be used to control the composition of the intestinal flora in a controlled, clinically feasible way to study the effects of particular types of intestinal microorganisms on the host.

Under normal circumstances, very few HPCs are evident in the liver. This finding contrasts with the situation in many other organs and tissues, such as the intestine and hair follicles, in which progenitor cells continuously divide and supply new daughter cells. Under normal circumstances, adult liver parenchymal cells remain in the G0 phase. However, when the liver suffers a major insult, such as hepatectomy or toxic damage, the main source of daughter cells tends to be the hepatic parenchymal cells. Only if the division of hepatic parenchymal cells is inhibited, such as during chronic liver failure, are HPCs activated, and these cells proliferate and differentiate to generate new hepatic parenchymal cells and cholangiocytes. In this study, the depletion of the gut microbiome not only negatively affected liver health but also induced a ductular reaction; and the progenitor markers SOX9 and CK were expressed in larger quantities around the lumen.

Interleukin‐6 is a cytokine that has multiple effects and redundant activities. IL‐6 is mainly produced by macrophages in response to PAMPs and damage‐associated molecular patterns (Jinkawa et al., [2019](#mbo3873-bib-0036){ref-type="ref"}); IL‐6 plays a role in the removal of infectious agents during the acute phase and during immune responses to protect and repair the damaged tissue (Gonzalez et al., [2018](#mbo3873-bib-0020){ref-type="ref"}; Mendlovic et al., [2017](#mbo3873-bib-0054){ref-type="ref"}). IL‐6 can be used as a biomarker of disease severity and as a prognostic indicator (Jang et al., [2012](#mbo3873-bib-0034){ref-type="ref"}); in addition, its expression is always higher than that of TNF‐α and IL‐1β. IL‐6 has traditionally been considered an obvious proinflammatory cytokine. IL‐6 is involved in the development of tumors associated with inflammation and the regulation of innate and/or adaptive immune responses (Chen et al., [2018](#mbo3873-bib-0008){ref-type="ref"}; Giardino et al., [2017](#mbo3873-bib-0019){ref-type="ref"}). In addition to its deleterious effects on inflammation and cancer, IL‐6 has been shown to have a regenerative and antiinflammatory potential (Naseem, Hussain, & Manzoor, [2018](#mbo3873-bib-0063){ref-type="ref"}).

Transmembrane IL‐6 receptor expression was limited to the surface of liver cells and to some leukocytes. Another molecule, called soluble IL‐6 receptor (sIL‐6R), is present in the tissue fluid and serum and makes it possible to combine IL‐6 with many other cell types (Tanaka & Kishimoto, [2014](#mbo3873-bib-0083){ref-type="ref"}). This allows IL‐6 to be delivered to the cells that do not express the IL‐6 receptor. The IL‐6/IL‐6R complex binds to the signal transducer gp130 to activate the Janus Kinase (JAK) and the signal transducer and activator of transcription 3 (STAT3) pathways (Kubo, Hanada, & Yoshimura, [2003](#mbo3873-bib-0042){ref-type="ref"}). The activation of the mitogen‐activated protein kinase (MAPK) signaling pathway in rapidly proliferating cells is usually observed after IL‐6 stimulation (2003, Jones, Horiuchi, Topley, Yamamoto, & Fuller, [2001](#mbo3873-bib-0037){ref-type="ref"}), and IL‐6 signaling directly activates the prosurvival phosphatidylinositol 3‐kinase/Akt pathway (Levy & Lee, [2002](#mbo3873-bib-0043){ref-type="ref"}).

Although IL‐6 is associated with many liver diseases and cancers, it is also crucial for liver regeneration (Naseem et al., [2018](#mbo3873-bib-0063){ref-type="ref"}). IL‐6 mediates various pathways in the liver, including immediate early gene transcription, DNA repair, glycogen storage, antioxidant activity, angiogenesis, cell proliferation, and liver protection. IL‐6R and gp130 are widely expressed in all liver cells, including Kupffer cells, hepatic stellate cells, hepatocytes, and sinus endothelial cells. IL‐6 has been shown to regulate HPCs (Lu et al., [2015](#mbo3873-bib-0051){ref-type="ref"}). By IL‐6/STAT3 signal transduction, HPCs proliferated and supported liver regeneration, while the absence of IL‐6 would limit the proliferation of HPCs and reduce liver regeneration (Yeoh et al., [2007](#mbo3873-bib-0099){ref-type="ref"}). In addition, the number of HPCs in IL‐6‐deficient mice decreased, and in the absence of IL‐6 signaling, more liver failure with cell necrosis and impaired regeneration occurred (Cressman et al., [1996](#mbo3873-bib-0012){ref-type="ref"}).

TWEAK, a member of the TNF superfamily, is expressed in multiple tissues. The many biological functions of TWEAK include the regulation of cell apoptosis and necrosis, proliferation, migration, and differentiation; in addition, this protein can trigger angiogenesis and induce the expression of inflammatory cytokines (Xu, Zhao, & Liu, [2016](#mbo3873-bib-0096){ref-type="ref"}). TWEAK has only one receptor, fibroblast growth factor‐inducible 14 (Fn14), which is a type I transmembrane protein, and TWEAK is the only ligand of Fn14. TWEAK is widely expressed in dendritic cells, monocytes, macrophages, and natural killer cells (Liu, Xiao, & Xia, [2017](#mbo3873-bib-0047){ref-type="ref"}). Among inflammatory cells, macrophages and monocytes are the main sources of TWEAK, while in normal tissues, the expression levels of TWEAK and Fn14 are very low. Higher levels of TWEAK and Fn14 expression usually appear in response to stress, tissue damage, or remodeling; this expression can also occur in connection with many other disorders, including autoimmune diseases and cancers (Gu et al., [2013](#mbo3873-bib-0022){ref-type="ref"}; Wang et al., [2017](#mbo3873-bib-0091){ref-type="ref"}), triggering the activation of multiple downstream signaling pathways that can modify these tissues.

Jakubowski et al. ([2005](#mbo3873-bib-0033){ref-type="ref"}) suggested that TWEAK is a direct mitogen of HPCs. Fn14 has no intrinsic protein kinase activity and is associated with tumor necrosis factor receptor--associated factor receptor molecules to trigger activated nuclear factor kappa light chain enhancer of activated B cells (NFκB) (Tirnitz‐Parker et al., [2010](#mbo3873-bib-0088){ref-type="ref"}); extracellular signaling regulates the kinase and MAPK pathway of c‐Jun N‐terminal kinase. Feng et al. ([2000](#mbo3873-bib-0013){ref-type="ref"}) reported a rapid induction of Fn14 expression in early liver regeneration after partial hepatectomy. The authors also studied hepatocellular carcinoma cell lines, where the overexpression of Fn14 occurred in poorly differentiated cell lines. This suggests that it may be linked to progenitor cells. Jakubowski et al. confirmed this hypothesized relationship between HPCs and Fn14 signaling pathways with experiments. Their study showed that TWEAK overexpression by the transgenic or adenovirus methods can induce the HPC response. In the mouse model of oval cell (another name for HPCs in rodents) proliferation, TWEAK/Fn14 knockout inhibited the appearance of HPCs. In addition, TWEAK can directly induce the proliferation of bile duct epithelial cell lines with progenitor characteristics (Liu et al., [2015](#mbo3873-bib-0046){ref-type="ref"}).

Because all of these inflammatory cytokines can be secreted by macrophages, these cells are likely to play a central role in the activation of HPCs in response to gut microbial depletion. We may speculate that with the removal of intestinal bacteria, intestinal homeostasis is disrupted and permeability is increased, causing LPS to leak into the blood. Excessive LPS activates the macrophages in the liver. Activated macrophages secrete inflammatory cytokines, especially IL‐6 and TWEAK. One pathway is that IL‐6 binds to IL‐6R and then binds to gp130, thereby activating the JAK/STAT 3 signaling pathway and activating the HPC response; the other pathway is that TWEAK binds to Fn14 to activate NFκB, thereby activating the HPC response. However, the specific mechanisms need to be defined, and there may be other mechanisms involved.

To our knowledge, our study is the first to demonstrate a link between the gut microbiome and HPC activation. We have demonstrated that the elimination of the vast majority of intestinal microbes can stimulate HPC activation, suggesting that HPC activity may be triggered by microbial dysbiosis. The mechanism underlying this phenomenon may involve the release of proinflammatory cytokines, especially IL‐6 and TWEAK, with macrophages playing a major role during this process. Further work is necessary to illuminate the precise mechanisms.

4. MATERIALS AND METHODS {#mbo3873-sec-0008}
========================

4.1. Mice {#mbo3873-sec-0009}
---------

Male C57BL/6 mice were purchased from Beijing Vital River Laboratory (China). According to the national standard (GB 14925‐2001), we housed the specific‐pathogen‐free grade mice in a barrier system under strict microorganism control and a controlled 12‐hr light‐dark cycle. Eight‐week‐old mice were used in the experiments.

The cocktail of antibiotics used consisted of neomycin (2 mg/ml, neomycin sulfate, HY‐B0470, MedChem Express \[MCE\]), meropenem (1 mg/ml, meropenem Trihydrate, M2279, J&K Scientific, China), bacitracin (5 mg/ml, 184862, J&K Scientific), vancomycin (1 mg/ml, vancomycin hydrochloride extracted from *Streptomyces orientalis*, 122263, J&K Scientific), and natamycin (1.2 μg/ml, HY‐B0133, MCE), which were all dissolved in autoclaved water (Frohlich et al., [2016](#mbo3873-bib-0014){ref-type="ref"}; Guida et al., [2018](#mbo3873-bib-0023){ref-type="ref"}; Kiraly et al., [2016](#mbo3873-bib-0038){ref-type="ref"}) and were included in the drinking water of the mice for 14 days to ablate the gut microbiome. At the end of the experiment, the mice were anesthetized with 5% chloral hydrate, blood was collected from the retro‐orbital sinus, and then the mice were sacrificed by cervical dislocation. The ceca and livers were collected. A portion of each liver was snap‐frozen in liquid nitrogen for subsequent qPCR, and another portion was immersed in 4% paraformaldehyde for subsequent paraffin embedding. The cecal samples were snap‐frozen and then placed in a −80°C freezer. The blood samples were centrifuged for 10 min at 1,000×*g*, and then the serum samples was collected and delivered at 4°C to the Capital Medical University Clinical Laboratory Center for the assays.

4.2. LPS ELISA analysis {#mbo3873-sec-0010}
-----------------------

The ELISA Kit for LPS was purchased from Cloud‐Clone Corp. According to the instruction manual, 100 μl each of the standard dilution, blank and serum samples was added to the appropriate wells. The plate was covered with a sealer and was incubated at 37°C for 1 hr. Then, the liquid was removed, and 100 μl of Detection Reagent A was added to each well; the plate was covered and incubated at 37°C for 1 hr. Subsequently, the liquid was discarded, and 350 μl of 1x Wash Solution was added to each well followed by a 1--2 min incubation. The wash step was repeated three times. The plate was turned upside down and tapped onto absorbent paper to remove the excess liquid. Then, 100 μl of Detection Reagent B was added to each well, and the plate was covered and incubated for 30 min at 37°C. The abovementioned washing process was repeated five times. Subsequently, 90 μl of Substrate Solution was added to each well, and the plate was covered and incubated in the dark at 37°C for 10--20 min until the standard liquid turned blue. Next, 50 μl of Stop Solution was added to each well to terminate the reaction, and the liquid turned yellow. The bubbles on the surface of the liquid were avoided, and the absorbance was immediately measured at 450 nm.

4.3. Mouse cecal DNA isolation and 16S rRNA sequencing analysis {#mbo3873-sec-0011}
---------------------------------------------------------------

Metagenomic DNA was extracted from the cecal contents using the Powersoil DNA Isolation Kit (MoBio) according to the manufacturer\'s instructions. Then, 0.25 g of the cecal contents was added to the PowerBead tubes and was gently vortexed. Next, 60 μl of Solution C1 was added to the tubes and was centrifuged at 10,000×*g* for 30 s at room temperature (RT). A new 2 ml collection tube was utilized to collect the supernatant. Subsequently, 250 μl of Solution C2 was added, followed by vortexing and incubation at 4°C for 5 min. After centrifugation at 10,000×*g* for 1 min at RT, 500 μl of the supernatant was transferred to a new 2 ml collection tube. Then, 200 μl of Solution C3 was added, followed by vortexing, incubation at 4°C for 5 min and centrifugation at 10,000×*g* for 1 min at RT. Subsequently, 700 μl of supernatant was transferred to a new 2 ml collection tube, and 1,200 μl of Solution C4, which was shaken before use, was added to the supernatant and vortexed slightly. Each sample was processed by loading three times (675 μl each) onto a spin filter and centrifuging at 10,000×*g* for 1 min at RT; the flow through was discarded every time. Next, 500 μl of Solution C5 was added, followed by centrifuging at 10,000×*g* for 30 s at RT, discarding the flow through, and centrifuging again at 10,000×*g* for 1 min at RT. The spin filter was carefully placed into a new 2 ml collection tube, 100 μl of Solution C6 was added to the center of the filter membrane, and the filter was centrifuged at 10,000×*g* for 30 s at RT. The spin filter was discarded. The DNA in the tube was used for subsequent experiments. The bacterial 16S rRNA gene was amplified by qPCR using universal primers; the amplified 16S rRNA, which was normalized to glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) expression level, was proportional to the number of intestinal bacteria present.

4.4. RNA extraction and quantitative real‐time PCR {#mbo3873-sec-0012}
--------------------------------------------------

Two‐millimeter‐cubed portions of frozen liver or 1--2 mm portions of the colon were used to obtain total RNA using TRIzol Reagent (Invitrogen) according to the manufacturer\'s instructions. The individual portions were ground at a low temperature in 1 ml TRIzol Reagent and were placed at RT for 5 min. Then, 200 μl of trichloromethane was added, and the tubes were vigorously vortexed, placed at RT for 3 min, and centrifuged at 12,000×*g* for 15 min at 4°C. The supernatant was carefully transferred to new tubes (140 μl × 2 = 280 μl), mixed with an equal volume of isopropanol, blended by gently inverting and centrifuged at 12,000×*g* for 15 min at 4°C. The supernatant was discarded, and 1 ml of 75% alcohol‐diethyl pyrocarbonate (DEPC) solution was added to rinse the sediment, followed by centrifugation at 8,000×*g* for 5 min at 4°C. The supernatant was discarded, and the pellet was air‐dried for 5--10 min followed by the addition of 30 μl DEPC to dissolve the sediment‐acquired RNA solution. Then, reverse transcription was performed using a cDNA Synthesis Kit (Roche) according to the manufacturer\'s instructions. Relative mRNA expression was measured by qPCR using SYBR Green PCR Master Mix (Roche). GAPDH mRNA was amplified in parallel as a reference gene. The primer sequences are shown in Table [1](#mbo3873-tbl-0001){ref-type="table"}.

###### 

Real‐time PCR primers

          *F* (5′ to 3′)           R (5′ to 3′)
  ------- ------------------------ ------------------------
  Sox9    TGAAGAACGGACAAGCGGAG     CAGCTTGCACGTCGGTTTTG
  Tgfb1   AGGAGACGGAATACAGGGCT     ATGTCATGGATGGTGCCCAG
  ALR     AGGAACCAGCCAGACACAAG     CGCCAACGCTCATCTACTCT
  IL‐6    AGGAGACTTCACAGAGGATACC   GAATTGCCATTGCACAACTCTT
  TNF‐α   AGGGTCTGGGCCATAGAACT     CCACCACGCTCTTCTGTCTAC
  IL‐1β   GTGTCTTTCCCGTGGACCTT     CGTCACACACCAGCAGGTTA
  TWEAK   CCAGACAGAGGAAAGCCAGG     CTCACTGTCCCATCCACACC
  ZO‐1    GAGCTACGCTTGCCACACTGT    TCGGATCTCCAGGAAGACACTT

John Wiley & Sons, Ltd

4.5. Immunohistochemistry {#mbo3873-sec-0013}
-------------------------

Liver paraffin sections (5 μm thick) were successively dewaxed in xylene and were rehydrated in gradient alcohol solutions. A rabbit polyclonal antibody against SOX9 (ab26414, Abcam), an anti‐pan‐CK polyclonal rabbit antibody (Z0622, Dako), a rabbit polyclonal antibody against CD68 (ab125212) and a rabbit polyclonal antibody against ZO‐1 (40‐2200, Invitrogen) were applied (1:200), and the slides were incubated overnight at 4°C followed by rinsing with PBS. The liver sections were then incubated with a secondary antibody (PV‐6001, ZSbio, Beijing, China) for 1 hr, and the antibody was detected using DAB. The sections were counterstained in hematoxylin for 15 s, washed with tap water, dehydrated and mounted using neutral balsam. The results were analyzed by an independent, trained observer who was blinded to the experimental treatment conditions, and both the number of cells and the total density of the immunoreactive material were determined using ImageJ software.

4.6. Statistical analysis {#mbo3873-sec-0014}
-------------------------

Each result is presented as the mean ± SEM of at least three independent experiments. The differences between the two groups were analyzed using Student\'s *t* test. Statistical significance was calculated using SPSS package version 17.0, with *p* \< 0.05 considered to represent statistical significance.
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